ECDC and EMCDDA joint guidance report on reducing infections among people who inject drugs.
نویسندگان
چکیده
On 12 October 2011, the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published a joint guidance on the prevention and control of infectious diseases among people who inject drugs [1]. The two agencies of the European Union (EU) bring together know-how from the fields of drugs and infections, assess the evidence-base for interventions as well as European good practice and expert knowledge in the guidance document to inform the development, monitoring and evaluation of national and regional strategies to reduce and prevent infections among people who inject drugs.
منابع مشابه
A perspective from drug user organisations on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’
ECDC and EMCDDA Guidance: Prevention and Control of Infectious Diseases among People Who Inject Drugs [1] draws on scientific evidence to identify key components of infectious disease interventions for people who inject drugs (PWID). This commentary presents an assessment of the document from the perspective of five Spanish drug user organisations. In addition to noting ways in which we think t...
متن کاملA policy-maker’s perspective on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’
In late 2011, the European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published ECDC and EMCDDA Guidance: Prevention and Control of Infectious Diseases among People Who Inject Drugs [1]. This document synthesised evidence-based good practices and expert opinion into a body of pragmatic recommendations for European policy...
متن کاملImproving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs
Introduction The hepatitis C virus (HCV) is 5 to 20 times more infectious than HIV [1]. Even more alarmingly, HCV has the capacity to survive outside of the human body for weeks. Unfortunately, this makes the reuse of injecting equipment that has been contaminated with HCV a highly effective means of spreading the disease [2]. The prevalence of HCV among people who inject drugs (PWID) is shocki...
متن کاملExamining the Potential Role of a Supervised Injection Facility in Saskatoon, Saskatchewan, to Avert HIV among People Who Inject Drugs
Background Research predicting the public health and fiscal impact of Supervised Injection Facilities (SIFs), across different cities in Canada, has reported positive results on the reduction of HIV cases among People Who Inject Drugs (PWID). Most of the existing studies have focused on the outcomes of Insite, located in the Vancouver Downtown Eastside (DTES). Previous attention has not been af...
متن کاملPrevalence and Associated Risk Factors of HTLV/HIV Co-Infection among People who inject Drugs (PWIDs): A Review
Submit Manuscript | http://medcraveonline.com Abbreviations: HTLVs: Human T-Cell Lymphotropic Viruses; HTLV-1: Human T-Cell Lymphotropic Virus Type 1; HTLV2: Human T-Cell Lymphotropic Virus Type 2; HIV: Human Immunodeficiency Virus; STLV-1: Simian T-Cell Lymphotropic Virus Type 1; PWIDs: People Who Inject Drugs; IDU: Intravenous Drug Use; AIDS: Acquired Immune Deficiency Syndrome; HBV: Hepatiti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
دوره 16 41 شماره
صفحات -
تاریخ انتشار 2011